(And Which Were Reinforced by My Drug Reps)
Gary G. Kohls, Duty to Warn / Special to Evergreene Digest
If you like reading this article, consider contributing a cafe latte to all-reader supported Evergreene Digest--using the donation button in the above right-hand corner—so we can bring you more just like it.
Oct 7, 2013 | Myth # 1: “The FDA (US Food and Drug Administration) tests all new psychiatric drugs”
Actually the FDA only reviews studies that have been designed, administered and paid for by the drug companies. The studies are frequently conducted by well-paid research firms, in whose interest it is that positive results are obtained for their corporate employers, who are likewise poised to make billions of dollars if the “correct” results are obtained. Unsurprisingly, it has become rare for such research to result in negative findings for the drug company. Fraud in such research has been rampant for decades.
Myth # 2: “FDA approval means that a psychotropic drug is effective long-term.”
Actually, FDA approval doesn’t even mean the drugs are effective short term. The pharmaceutical industry has cunningly infiltrated and also partially funds (or perhaps “bribes” is the better word) various physician “experts” with Big Pharma connections on many of the FDA committees that “fast track” drugs through the approval process. The FDA only receives studies that report short-term effectiveness from the pharmaceutical corporations who are hoping for rapid marketing approval. In the case of the SSRI drugs during the 1990s and 2000s, animal lab studies typically lasted only hours, days or weeks and the human clinical studies only lasted, on average, 6-8 weeks, far too short to say anything about long-term effectiveness!
Gary G. Kohls is a family physician who, until his retirement in 2008, practiced holistic (non-drug) mental health care. He is a past member of MindFreedom International, the International Center for the Study of Psychiatry and Psychology and the International Society for Traumatic Stress Studies.